Cavan John T 4
4 · Hepion Pharmaceuticals, Inc. · Filed May 20, 2021
Insider Transaction Report
Form 4
Cavan John T
Chief Financial Officer
Transactions
- Award
Stock Options
2021-05-18+1,200,000→ 1,581,060 totalExercise: $1.70Exp: 2031-05-18→ Common Stock (1,200,000 underlying)
Footnotes (2)
- [F1]Stock Options have been granted subject to stockholder approval of an increase in the shares of common stock issuable pursuant to the 2013 Equity Incentive Plan.
- [F2]400,000 of the stock options vest on 5/18/2022 and the remainder vests monthly in equal amounts over 24 months.